Title
Category
Credits
Event date
Cost
  • Biopsychosocial
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 APA
  • 1.00 ASWB-ACE
  • 1.00 Contact Hours/ Participation
$0.00
In the last two decades, psychedelics have re-emerged as promising novel agents for treatment of a broad range of mental health conditions including depression, PTSD, substance use disorders, end-of-life anxieties, eating disorders, and more. Our understanding of their putative mechanisms of action has significantly evolved as well. Several Phase II and III clinical trials of psychedelic-assisted therapy (PAT) using psilocybin and MDMA are either complete or nearing completion, with some of these therapies projected to receive FDA approval within the next couple of years.
  • Biopsychosocial
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 APA
  • 1.00 ASWB-ACE
  • 1.00 Contact Hours/ Participation
$0.00
This forum uses Thomas Kohut’s recent book, Empathy and the Historical Understanding of the Human Past (Routledge, 2020), as a springboard for an interdisciplinary discussion of empathy and its role in understanding people in the past and in the present. 
  • Biopsychosocial
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 APA
  • 1.00 ASWB-ACE
  • 1.00 Contact Hours/ Participation
$0.00
This presentation will focus on the dimensional nature of personality, emphasizing a continuum model from personality styles to personality disorders. The development of the Alternative Model for DSM-5 Personality Disorders will be described, reviewing the hybrid nature of the model that incorporates two dimensional components: 1) level of impairment in functioning, and 2) pathological personality trait domains and trait facets. The utility of the AMPD for routine clinical use will be discussed. References

Pages